Back to Journals » Substance Abuse and Rehabilitation » Volume 3 » Supplement 1

Meeting the substance abuse treatment needs of lesbian, bisexual and transgender women: implications from research to practice

Authors Stevens S

Received 22 September 2011

Accepted for publication 5 November 2011

Published 1 February 2012 Volume 2012:3(Supplement 1) Pages 27—36


Review by Single-blind

Peer reviewer comments 4

Sally Stevens

Southwest Institute for Research on Women (SIROW) and Department of Gender and Women’s Studies (GWS), University of Arizona, Tucson, AZ, USA

Abstract: Research on the incidence, etiology and substance abuse treatment needs of lesbian, bisexual and transgender (LBT) women is limited. Most research indicates higher levels of alcohol and drug abuse among these populations compared to their heterosexual counterparts, with recent research indicating that substance abuse is a particular concern for transgender individuals and an increasing problem among younger LBT individuals. Risk factors and reasons for substance abuse among sexual minority women are similar to those of heterosexual women, yet are substantially complicated by issues of family rejection and lack of social support, stigma and minority stress, as well as abuse and harassment. Historically, substance abuse prevention, early intervention, and clinical treatment programs were designed to meet the needs of the sexual majority population with relatively few programs designed to incorporate the specific needs of sexual minorities. This article reviews findings from previous studies and utilizes new data collected from community-based and residential substance abuse treatment programs to (1) examine issues relevant to LBT women and substance use, and (2) make recommendations for tailoring substance abuse treatment programs to meet the needs of these populations.

Keywords: lesbian, bisexual, transgender, substance abuse, family rejection, social support, stigma, minority stress, abuse, harassment

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Readers of this article also read:

Decreased bacteria activity on Si3N4 surfaces compared with PEEK or titanium

Gorth DJ, Puckett S, Ercan B, Webster TJ, Rahaman M, Bal BS

International Journal of Nanomedicine 2012, 7:4829-4840

Published Date: 7 September 2012

Prevention interventions for human immunodeficiency virus in drug-using women with a history of partner violence

Stockman JK, Ludwig-Barron N, Hoffman MA, Ulibarri MD, Penniman Dyer TV

Substance Abuse and Rehabilitation 2012, 3:45-57

Published Date: 1 February 2012

Six-month follow-up of Iranian women in methadone treatment: drug use, social functioning, crime, and HIV and HCV seroincidence

Dolan K, Salimi S, Nassirimanesh B, Mohsenifar S, Allsop D, Mokri A

Substance Abuse and Rehabilitation 2012, 3:37-43

Published Date: 1 February 2012

Long-term residential substance abuse treatment for women: lessons learned from Israel

Schori M, Sapir Y, Lawental E

Substance Abuse and Rehabilitation 2012, 3:71-81

Published Date: 1 February 2012

Clinical update on the use of biomarkers of airway inflammation in the management of asthma

Wadsworth SJ, Sin DD, Dorscheid DR

Journal of Asthma and Allergy 2011, 4:77-86

Published Date: 30 June 2011